Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ECYT
Delisted

Endocyte Fund Price (Quote)

$23.99
+0 (+0%)
At Close: Jan 18, 2019

Range Low Price High Price Comment
30 days $23.97 $24.00 Friday, 18th Jan 2019 ECYT stock ended at $23.99. During the day the stock fluctuated 0% from a day low at $23.99 to a day high of $23.99.
90 days $23.37 $24.00
52 weeks $2.81 $24.00

Historical Endocyte prices

Date Open High Low Close Volume
May 09, 2018 $11.43 $12.11 $11.01 $12.00 1 448 871
May 08, 2018 $11.72 $11.72 $10.85 $11.05 1 264 425
May 07, 2018 $10.86 $12.19 $10.86 $11.49 2 659 921
May 04, 2018 $10.83 $10.99 $10.61 $10.89 667 873
May 03, 2018 $10.35 $10.84 $10.35 $10.81 792 890
May 02, 2018 $9.61 $10.44 $9.61 $10.34 1 572 836
May 01, 2018 $9.55 $9.72 $9.27 $9.59 419 867
Apr 30, 2018 $9.40 $9.77 $9.31 $9.57 603 788
Apr 27, 2018 $9.33 $9.51 $9.25 $9.40 494 067
Apr 26, 2018 $9.03 $9.47 $8.94 $9.33 716 790
Apr 25, 2018 $9.02 $9.23 $8.75 $9.03 559 187
Apr 24, 2018 $9.20 $9.65 $8.85 $8.98 594 685
Apr 23, 2018 $9.37 $9.46 $9.02 $9.16 619 473
Apr 20, 2018 $9.66 $9.73 $9.25 $9.41 650 382
Apr 19, 2018 $9.70 $9.96 $9.57 $9.62 599 214
Apr 18, 2018 $10.04 $10.07 $9.57 $9.73 1 053 151
Apr 17, 2018 $9.27 $10.10 $9.25 $10.05 1 381 470
Apr 16, 2018 $9.68 $9.78 $8.76 $9.23 977 567
Apr 13, 2018 $10.16 $10.63 $9.52 $9.52 3 113 311
Apr 12, 2018 $9.17 $9.61 $9.17 $9.55 728 887
Apr 11, 2018 $8.72 $9.55 $8.55 $9.15 1 899 691
Apr 10, 2018 $8.29 $9.30 $8.25 $8.84 1 899 772
Apr 09, 2018 $8.27 $8.50 $8.03 $8.20 781 075
Apr 06, 2018 $8.44 $8.60 $8.18 $8.30 707 106
Apr 05, 2018 $8.84 $8.87 $8.31 $8.45 846 184
Click to get the best stock tips daily for free!

About Endocyte

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its technology to create novel small molecule drug conjugates (SMDCs) and companion imaging agents. It is developing Vintafolide, a SMDC that is in Phase IIb clinical trials to treat non-small cell lung cancer; EC1456, which is in Phase I dose escalation trial for the treatment of ad... ECYT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT